Abstract: A system for optimizing the selection of transcription engines is provided. The system includes an alphanumeric preprocessor, an audio analysis preprocessor, a categorical preprocessor, and a continuous variable preprocessor which is configured to receive outputs from the alphanumeric, the audio analysis, and the categorical preprocessors and to generate data used by a modeling module to create a list of ranked transcription engines. The transcription engines are used to generate transcriptions of media data sets.

Abstract: A system for optimizing selection of transcription engines using a combination of selected machine learning models. The system includes a plurality of preprocessors that generate a plurality of features from a media data set. The system further includes a deep learning neural network model, a gradient boosted machine model and a random forest model used in generating a ranked list of transcription engines. A transcription engine is selected from the ranked list of transcription engines to generate a transcript for the media dataset.

Abstract: In one embodiment, a method includes accessing a first event profile that includes a seed event parameter and a first event parameter, calculating fraud scores for the first event parameter, accessing a second event profile that includes a second event parameter that corresponds to the first event parameter, calculating a fraud score for the second event parameter, and then identifying the second parameters as being associated with fraud. Fraud scores may be calculated based on the attributes of a parameter, the relation of the parameter to the seed parameter, and the fraud scores of any corresponding parameters.

Abstract: A method of predicting disk drive failure at a central processing facility using an evolving drive failure prediction algorithm (DFPA) is disclosed. A set of quality metric values are transmitted from each of a plurality of remote disk drives to the central processing facility. The DFPA is executed at the central processing facility in response to the quality metric values to detect an impending failure of at least one of the remote disk drives. The DFPA is evolved at the central processing facility in response to a reference data base of quality metric values and a corresponding failure indicator. The processes is repeated so as to improve the accuracy of the DFPA over time.

Abstract: A method of binning disk drives by evaluating quality metrics prior to a final quality audit is disclosed. A number of disk drives are assembled, and a plurality of quality metrics are generated for each disk drive representing a plurality of operating characteristics. The quality metrics for each disk drive are evaluated for binning the disk drives into a plurality of lots including a first lot and a second lot. A final quality audit (FQA) is performed by executing a number of write and read operations for a plurality of the disk drives in each lot and classifying each disk drive as passing or failing the FQA. If the number of disk drives that fail the FQA out of the first lot falls below a first threshold, the first lot is classified as acceptable for a first tier customer. If the number of disk drives that fail the FQA out of the second lot falls below a second threshold, the second lot is classified as acceptable for a second tier customer.

Abstract: A subset of quality metrics as input to a disk drive failure prediction algorithm (DFPA) may be selected using a genetic algorithm. The DFPA is executed for an initially selected generation of subset quality metrics using quality metric values stored in a reference data base. At least one DFPA setting is adjusted and the DFPA executed again for the selected subset. After training the DFPA, the best DFPA setting is saved for the selected subset. A fitness score is generated for the selected subset, representing an accuracy of the DFPA relative to failure indicators stored in the reference data base. At least one genetic operator is applied in response to the fitness scores to generate a new generation of subsets. The process is repeated until a best subset of quality metrics and corresponding DFPA setting are found.

Abstract: A fractionation system comprising means for forming a three dimensional optical lattice that is operable to separate particles that have different physical characteristics. Preferably, the wells of the optical lattice are interlinked. For example, the wells may be linked in such a manner as to provide deflection greater than or equal to 15 degrees.

Abstract: It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans. Phosphoinositides useful with the present invention have the following formula: wherein R1 and R2 are selected from the group consisting of hydrogen and monounsaturated and saturated fatty acids having a carbon chain length of C6 to C20 and R1 and R2 can be the same or different; and R3 to R7 are selected from the group consisting of hydrogen or a phosphate moiety with at least two of R3 to R7 being a phosphate moiety; and hydrates and pharmaceutically acceptable salts thereof.

Abstract: An extraction system comprises a canopy for receiving fumes. An aperture is defined in the top of the canopy, and dusting extends from the canopy, in communication with the fumes at the aperture, to an in-line extractor fan. Further ducting extends from the in-line extractor fan to an external extractor fan. A path for the extraction of fumes by the system is defined by the inner surfaces of the canopy, the ductings and the casings of the extractor fans. The inner surfaces of each of these components are coated with a non-stick, heat resistant material such as polytetrafluoroethene (PTFE).

Abstract: It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans.

Abstract: It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans. Phosphoinositides useful with the present invention have the following formula: wherein R1 and R2 are selected from the group consisting of hydrogen and monounsaturated and saturated fatty acids having a carbon chain length of C6 to C20 and R1 and R2 can be the same or different; and R3 to R7 are selected from the group consisting of hydrogen or a phosphate moiety with at least two of R3 to R7 being a phosphate moiety; and hydrates and pharmaceutically acceptable salts thereof.

Abstract: The present invention is directed to a rice flour extract (RFE) which can be used in the prophylaxis and treatment of bacterial infections, particularly bacterial infections caused by Haemophilus influenzae and to a method of preparing and using such an antibacterial rice flour extract. The anti-Haemophilus influenzae rice flour extract of the present invention can be prepared from commercial food grade rice flours or non-commercial food grade rice flours.

Abstract: A method of treating pneumonia or other respiratory disease caused by respiratory syncytial virus, adenovirus, parainfluenza virus, or influenza virus by orally administering a liquid, preferably an infant formula, containing a virus neutralizing antibody.

Abstract: The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human .beta.-casein, a recombinant form of human .beta.-casein, and hydrolysates of both. The human .beta.-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of otitis media in infants. The human .beta.-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.

Abstract: A method is provided for inhibiting rotavirus infection of human cells by treating the rotavirus with a carrageenan. The most effective agent in inhibiting cellular rotavirus infection is lambda-carrageenan, which may be formulated in a liquid and ingested enterally. A composition containing lambda-carrageenan is an aspect of the invention.

Abstract: The attachment of H. influenzae to human cells, such as oropharyngeal cells, may be inhibited by native human .beta.-casein, a recombinant form of human .beta.-casein, and hydrolysates of both. The human .beta.-casein or hydrolysate may be contained in a liquid enteral nutritional product such as an infant formula. The enteral nutritional product may be used, for example, in the prevention and treatment of otitis media in infants. The human .beta.-casein or hydrolysate may also be administered as a throat spray or nasally using drops or a spray.